down arrow

Pfizer

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE182A01018
  • NSEID: PFIZER
  • BSEID: 500680
INR
4,053.50
21.55 (0.53%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 10.59 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
ERIS Lifescience
Divi's Lab.
Cipla
Sun Pharma.Inds.
Concord Biotech
Torrent Pharma
Pfizer
Alembic Pharma
Mankind Pharma
Emcure Pharma
OneSource Speci.
Why is Pfizer Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 0.46% and Operating profit at 4.27% over the last 5 years
2
Negative results in Dec 24
  • PBT LESS OI(Q) At Rs 129.68 cr has Fallen at -18.2 %
  • PAT(Q) At Rs 127.60 cr has Fallen at -16.6 %
  • DEBTORS TURNOVER RATIO(HY) Lowest at 9.84 times
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 27-Mar-25 and has generated 2.15% returns since then
  • The stocks MACD and KST technical factors are also Bearish
4
With ROE of 16.4, it has a Very Expensive valuation with a 4.9 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -3.23%, its profits have risen by 20.3% ; the PEG ratio of the company is 1.5
5
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -3.23% returns in the last 1 year, the stock has also underperformed BSE 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Pfizer for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Pfizer
-3.19%
-0.12
27.78%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.46%
EBIT Growth (5y)
4.27%
EBIT to Interest (avg)
50.67
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.79
Tax Ratio
26.21%
Dividend Payout Ratio
29.04%
Pledged Shares
0
Institutional Holding
19.54%
ROCE (avg)
46.85%
ROE (avg)
19.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
30
Industry P/E
33
Price to Book Value
4.92
EV to EBIT
25.16
EV to EBITDA
23.07
EV to Capital Employed
10.75
EV to Sales
7.25
PEG Ratio
1.48
Dividend Yield
0.87%
ROCE (Latest)
43.00%
ROE (Latest)
16.41%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 2,281.32 cr

-11What is not working for the Company
PBT LESS OI(Q)

At Rs 129.68 cr has Fallen at -18.2 %

PAT(Q)

At Rs 127.60 cr has Fallen at -16.6 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 9.84 times

NET SALES(Q)

Lowest at Rs 537.99 cr

PBDIT(Q)

Lowest at Rs 145.99 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 27.14%

EPS(Q)

Lowest at Rs 27.89

Loading Valuation Snapshot...
Here's what is working for Pfizer
Cash and Cash Equivalents - Half Yearly
Highest at Rs 2,281.32 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Pfizer
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 129.68 cr has Fallen at -18.2 %
over average PBT of the previous four quarters of Rs 158.45 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 127.60 cr has Fallen at -16.6 %
over average PAT of the previous four quarters of Rs 153.01 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 537.99 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 145.99 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 27.14%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 129.68 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 27.89
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Lowest at 9.84 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio